Thematic review series: The immune system and atherogenesis. Cytokine regulation of macrophage functions in atherogenesis

Journal of Lipid Research

Volumn 46, Issue 9, 2005, Pages 1812-1822

  Daugherty, Alan ^a   Webb, Nancy R ^a   Rateri, Debra L ^a   King, Victoria L ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Coagulation; Lipoprotein; Matrix; Metabolism; Modification

Indexed keywords

ABC TRANSPORTER A1; CYTOKINE; CYTOKINE RECEPTOR; GAMMA INTERFERON; LIPID; LIPOPROTEIN; LIPOXYGENASE; LOW DENSITY LIPOPROTEIN RECEPTOR; MYELOPEROXIDASE; SCAVENGER RECEPTOR; VERY LOW DENSITY LIPOPROTEIN RECEPTOR;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD CLOTTING; CELL FUNCTION; CELL INTERACTION; CELL TYPE; CHEMOTAXIS; DOWN REGULATION; EXTRACELLULAR MATRIX; EXTRACELLULAR SPACE; HUMAN; IN VIVO STUDY; LIPID METABOLISM; LIPID OXIDATION; MACROPHAGE; MACROPHAGE MIGRATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; REVIEW; UPREGULATION;

ANIMALS; ARTERIOSCLEROSIS; BLOOD COAGULATION; CELLS, CULTURED; CYTOKINES; EXTRACELLULAR MATRIX; HUMANS; INTERFERON TYPE II; LIPID METABOLISM; LIPOPROTEINS; MACROPHAGES;

EID: 24344432048     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.R500009-JLR200     Document Type: Review

References (158)

1. Getz, G. S. 2005. Thematic review series: the immune system and atherogenesis. Immune function in atherogenesis. J. Lipid Res. 46: 1-10.
2. Raines, E. W., and N. Ferri. 2005. Cytokines affecting endothelial and smooth muscle cells in vascular diseases. J. Lipid Res. 46: 829-838.
3. Steinberg, D. 1997. Low density lipoprotein oxidation and its pathobiological significance. J. Biol. Chem. 272: 20963-20966.
4. Shishehbor, M. H., and S. L. Hazen. 2004. Inflammatory and oxidative markers in atherosclerosis: relationship to outcome. Curr. Atheroscler. Rep. 6: 243-250.
5. Hansson, G. K. 2001. Immune mechanisms in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 21: 1876-1890.
6. Gordon, S. 1995. The macrophage. Bioessays. 17: 977-986.
7. Goldstein, J. L., Y. K. Ho, and M. S. Brown. 1980. Cholesteryl ester accumulation in macrophages resulting from receptor-mediated uptake and degradation of hypercholesterolemic canine beta-very low density lipoproteins. J. Biol. Chem. 255: 1839-1848.
8. Du, B. H., C. Z. Fu, K. C. Kent, H. Bush, A. H. Schulick, K. Kreiger, T. Collins, and T. A. McCaffrey. 2000. Elevated Egr-1 in human atherosclerotic cells transcriptionally represses the transforming growth factor-beta type II receptor. J. Biol. Chem. 275: 39039-39047.
9. Okwu, A. K., X. X. Xu, Y. Shiratori, and I. Tabas. 1994. Regulation of the threshold for lipoprotein-induced acyl-CoA:cholesterol O-acyltransferase stimulation in macrophages by cellular sphingomyelin content. J. Lipid Res. 35: 644-655.
10. Daugherty, A., S. C. Whitman, A. E. Block, and D. L. Rateri. 2000. Polymorphism of class A scavenger receptors in C57BL/6 mice. J. Lipid Res. 41:1568-1577.
11. Kruth, H. S. 1985. Subendothelial accumulation of unesterified cholesterol. An early event in atherosclerotic lesion development. Atherosclerosis. 57: 337-341.
12. Frank, J. S., and A. M. Fogelman. 1989. Ultrastructure of the intima in WHHL and cholesterol-fed rabbit aortas prepared by ultra-rapid freezing and freeze etching. J. Lipid Res. 30: 967-978.
13. Quinn, M. T., S. Parthasarathy, L. G. Fong, and D. Steinberg. 1987. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc. Natl. Acad. Sci. USA. 84: 2995-2998.
14. Williams, K. J., and I. Tabas. 1995. The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15: 551-561.
15. Fong, L. G., T. S. E. Albert, and S. E. Hom. 1994. Inhibition of the macrophage-induced oxidation of low density lipoprotein by interferon-gamma. J. Lipid Res. 35: 893-904.
16. Christen, S., S. R. Thomas, B. Garner, and R. Stocker. 1994. Inhibition by interferon-gamma of human mononuclear cell-mediated low density lipoprotein oxidation-participation of tryptophan metabolism along the kynurenine pathway. J. Clin. Invest. 93: 2149-2158.
17. Sun, D. X., and C. D. Funk. 1996. Disruption of 12/15-lipoxygenase expression in peritoneal macrophages-enhanced utilization of the 5-lipoxygenase pathway and diminished oxidation of low density lipoprotein. J. Biol. Chem. 271: 24055-24062.
18. Ylä-Herttuala, S., M. E. Rosenfeld, S. Parthasarathy, C. K. Glass, E. Sigal, J. L. Witztum, and D. Steinberg. 1990. Colocalization of 15-lipoxygenase messenger RNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87: 6959-6963.
19. Ylä-Herttuala, S., M. E. Rosenfeld, S. Parthasarathy, E. Sigal, T. Sarkioja, J. L. Witztum, and D. Steinberg. 1991. Gene expression in macrophage-rich human atherosclerotic lesions-15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J. Clin. Invest. 87: 1146-1152.
20. Sendobry, S. M., J. A. Cornicelli, K. Welch, T. Bocan, B. Tait, B. K. Trivedi, N. Colbry, R. D. Dyer, S. J. Feinmark, and A. Daugherty. 1997. Attenuation of diet-induced atherosclerosis in rabbits with a highly selective 15-lipoxygenase inhibitor lacking significant antioxidant properties. Br. J. Pharmacol. 120: 1199-1206.
21. Cyrus, T, J. L. Witztum, D. J. Rader, R. Tangirala, S. Fazio, M. F. Linton, and C. D. Funk. 1999. Disruption of the 12/15-lipoxygenase gene diminishes atherosclerosis in apo E-deficient mice. J. Clin. Invest. 103: 1597-1604.
22. Zhao, L., C. A. Cuff, E. Moss, U. Wille, T. Cyrus, E. A. Klein, D. Pratico, D. J. Rader, C. A. Hunter, E. Pure, et al. 2002. Selective interleukin-12 synthesis defect in 12/15-lipoxygenase-deficient macrophages associated with reduced atherosclerosis in a mouse model of familial hypercholesterolemia. J. Biol. Chem. 277: 35350-35356.
23. Shen, J. H., E. Herderick, J. F. Cornhill, E. Zsigmond, H. S. Kim, H. Kuhn, N. V. Guevara, and L. Chan. 1996. Macrophage-mediated 15-lipoxygenase expression protects against atherosclerosis development. J. Clin. Invest. 98: 2201-2208.
24. Belkner, J., P. Chaitidis, H. Stender, C. Gerth, R. J. Kuban, T. Yoshimoto, and H. Kuhn. 2005. Expression of 12/15-lipoxygenase attenuates intracellular lipid deposition during in vitro foam cell formation. Arterioscler. Thromb. Vasc. Biol. 25: 797-802.
25. Conrad, D. J., H. Kuhn, M. Mulkins, E. Highland, and E. Sigal. 1992. Specific inflammatory cytokines regulate the expression of human monocyte 15-lipoxygenase. Proc. Natl. Acad. Sci. USA. 89: 217-221.
26. Nassar, G. M., J. D. Morrow, L. J. Roberts, F. G. Lakkis, and K. F. Badr. 1994. Induction of 15-lipoxygenase by interleukin-13 in human blood monocytes. J. Biol. Chem. 269: 27631-27634.
27. Cornicelli, J. A., D. Butteiger, D. L. Rateri, K. Welch, and A. Daugherty. 2000. Interleukin-4 augments acetylated LDL induced cholesterol esterification in macrophages. J. Lipid Res. 41: 376-383.
28. Sendobry, S. M., J. A. Cornicelli, K. Welch, M. J. Grusby, and A. Daugherty. 1998. Absence of T lymphocyte-derived cytokines fails to diminish macrophage 12/15-lipoxygenase expression in vivo. J. Immunol. 161: 1477-1482.
29. Daugherty, A., J. L. Dunn, D. L. Rateri, and J. W. Heinecke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94: 437-444.
30. Brennan, M. L., M. M. Anderson, D. M. Shih, X. D. Qu, X. Wang, A. C. Mehta, L. L. Lim, W. Shi, S. L. Hazen, J. S. Jacob, et al. 2001. Increased atherosclerosis in myeloperoxidase-deficient mice. J. Clin. Invest. 107: 419-440.
31. Podrez, E. A., H. M. Abu-Soud, and S. L. Hazen. 2000. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic. Biol. Med. 28: 1717-1725.
32. Heinecke, J. W. 2003. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am. J. Cardiol. 91: 12A-16A.
33. Sugiyama, S., Y. Okada, G. K. Sukhova, R. Virmani, J. W. Heinecke, and P. Libby. 2001. Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes. Am. J. Pathol. 158: 879-891.
34. Ylä-Herttuala, S., B. A. Lipton, M. E. Rosenfeld, I. J. Goldberg, D. Steinberg, and J. L. Witztum. 1991. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88: 10143-10147.
35. Babaev, V. R., S. Fazio, L. A. Gleaves, K. J. Carter, C. F. Semenkovich, and M. F. Linton. 1999. Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. J. Clin. Invest. 103: 1697-1705.
36. van Eck, M., R. Zimmermann, P. H. Groot, R. Zechner, and T. J. van Berkel. 2000. Role of macrophage-derived lipoprotein lipase in lipoprotein metabolism and atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20: E53-E62.
37. Wilson, K., G. L. Fry, D. A. Chappell, C. D. Sigmund, and J. D. Medh. 2001. Macrophage-specific expression of human lipoprotein lipase accelerates atherosclerosis in transgenic apolipoprotein E knockout mice but not in C57BL/6 mice. Arterioscler. Thromb. Vasc. Biol. 21: 1809-1815.
38. Jonasson, L., G. K. Hansson, G. Bondjers, L. Noe, and J. Etienne. 1990. Interferon-gamma inhibits lipoprotein lipase in human monocyte-derived macrophages. Biochim. Biophys. Acta. 1053: 43-48.
39. Querfeld, U., J. M. Ong, J. Prehn, J. Carty, B. Saffari, S. C. Jordan, and P. A. Kern. 1990. Effects of cytokines on the production of lipoprotein lipase in cultured human macrophages. J. Lipid Res. 31: 1379-1386.
40. Hughes, T. R., T. S. Tengku Muhammad, S. A. Irvine, and D. P. Ramji. 2002. A novel role of Sp1 and Sp3 in the interferon-gamma-mediated suppression of macrophage lipoprotein lipase gene transcription. J. Biol. Chem. 277: 11097-11106.
41. Argmann, C. A., C. H. van den Diepstraten, C. G. Sawyez, J. Y. Edwards, R. A. Kegele, B. M. Wolfe, and M. W. Huff. 2001. Transforming growth factor-beta 1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants. Arterioscler. Thromb. Vasc. Biol. 21: 2011-2018.
42. Irvine, S. A., P. Foka, S. A. Rogers, J. R. Mead, and D. P. Ramji. 2005. A critical role for the Sp1-binding sites in the transforming growth factor-beta-mediated inhibition of lipoprotein lipase gene expression in macrophages. Nucleic Acids Res. 33: 1423-1434.
43. Renier, G., E. Skamene, J. B. DeSanctis, and D. Radzioch. 1994. Induction of tumor necrosis factor alpha gene expression by lipoprotein lipase. J. Lipid Res. 35: 271-278.
44. Williams, K. J., G. M. Fless, K. A. Petrie, M. L. Snyder, R. W. Brocia, and T. L. Swenson. 1992. Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein (a), low density lipoprotein, and nascent lipoproteins-roles for low density lipoprotein receptors and heparan sulfate proteoglycans. J. Biol. Chem. 267: 13284-13292.
45. Jerome, W. G., and J. C. Lewis. 1997. Cellular dynamics in early atherosclerotic lesion progression in white carneau pigeons-spatial and temporal analysis of monocyte and smooth muscle invasion of the intima. Arterioscler. Thromb. Vasc. Biol. 17: 654-664.
46. Jerome, W. G., and P. G. Yancey. 2003. The role of microscopy in understanding atherosclerotic lysosomal lipid metabolism. Microsc. Microanal. 9: 54-67.
47. Boisvert, W. A., J. Spangenberg, and L. K. Curtiss. 1997. Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 17: 340-347.
48. Herijgers, N., M. van Eck, P. H. E. Groot, P. M. Hoogerbrugge, and T. J. C. van Berkel. 2000. Low density lipoprotein receptor of macrophages facilitates atherosclerotic lesion formation in C57B1/6 mice. Arterioscler. Thromb. Vasc. Biol. 20: 1961-1967.
49. Linton, M. F., V. R. Babaev, L. A. Gleaves, and S. Fazio. 1999. A direct role for the macrophage low density lipoprotein receptor in atherosclerotic lesion formation. J. Biol. Chem. 274: 19204-19210.
50. Soutar, A. K., and B. L. Knight. 1984. Degradation of lipoproteins by human monocyte-derived macrophages. Biochem. J. 218: 101-111.
51. Whitman, S. C., C. A. Argmann, C. G. Sawyez, D. B. Miller, K. A. Hegele, and M. W. Huff. 1999. Uptake of type IV hypertriglyceridemic VLDL by cultured macrophages is enhanced by interferon-gamma. J. Lipid Res. 40: 1017-1028.
52. Kosaka, S., S. Takahashi, K. Masamura, H. Kanehara, J. Sakai, G. Tohda, E. Okada, K. Oida, T. Iwasaki, H. Hattori, et al. 2001. Evidence of macrophage foam cell formation by very low-density lipoprotein receptor: interferon-gamma inhibition of very low-density lipoprotein receptor expression and foam cell formation in macrophages. Circulation. 103: 1142-1147.
53. Beisiegel, U., W. Weber, G. Ihrke, J. Herz, and K. K. Stanley. 1989. The LDL-receptor-related protein, LRP, is an apolipoprotein E-binding protein. Nature. 341: 162-164.
54. Herz, J., and D. K. Strickland. 2001. LRP: a multifunctional scavenger and signaling receptor. J. Clin. Invest. 108: 779-784.
55. LaMarre, J., B. B. Wolf, E. L. W. Kittler, P. J. Quesenberry, and S. L. Gonias. 1993. Regulation of macrophage alpha2-macroglobulin receptor/low density lipoprotein receptor-related protein by lipopolysaccharide and interferon-gamma. J. Clin. Invest. 91: 1219-1224.
56. Hussaini, I. M., J. LaMarre, J. J. Lysiak, L. R. Karns, S. R. VandenBerg, and S. L. Gonias. 1996. Transcriptional regulation of LDL receptor-related protein by IFN-gamma and the antagonistic activity of TGF-beta 1 in the RAW 264.7 macrophage-like cell line. J. Leukoc. Biol. 59: 733-739.
57. Garner, B., A. Baoutina, R. T. Dean, and W. Jessup. 1997. Regulation of serum-induced lipid accumulation in human monocyte-derived macrophages by interferon-gamma. Correlations with apolipoprotein E production, lipoprotein lipase activity and LDL receptor-related protein expression. Atherosclerosis. 128: 47-58.
58. Gonias, S. L., L. Wu, and A. M. Salicioni. 2004. Low density lipoprotein receptor-related protein: regulation of the plasma membrane proteome. Thromb. Haemost. 91: 1056-1064.
59. Brown, M. S., S. K. Basu, J. R. Falck, Y. K. Ho, and J. L. Goldstein. 1980. The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. J. Supramol. Struct. 13: 67-81.
60. Krieger, M., S. Acton, J. Ashkenas, A. Pearson, M. Penman, and D. Resnick. 1993. Molecular flypaper, host defense, and atherosclerosis-structure, binding properties, and functions of macrophage scavenger receptors. J. Biol. Chem. 268: 4569-4572.
61. de Winther, M. P., K, W. van Dijk, L. M. Havekes, and M. H. Hofker. 2000. Macrophage scavenger receptor class A: a multifunctional receptor in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 20: 290-297.
62. Daugherty, A., D. L. Rateri, and S. C. Whitman. 2000. Class A scavenger receptors: recent advances in elucidation of structure-function relationships and their role in atherosclerosis. Curr. Opin. Cardiovasc. Pulm. Ren. Investig. Drugs. 2: 223-232.
63. Fong, L. G., T. A. T. Fong, and A. D. Cooper. 1990. Inhibition of mouse macrophage degradation of acetyl low density lipoprotein by interferon-gamma. J. Biol. Chem. 265: 11751-11760.
64. Geng, Y. J., and G. K. Hansson. 1992. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J. Clin. Invest. 89: 1322-1330.
65. Horvai, A. E., L. Xu, E. Korzus, G. Brard, D. Kalafus, T. M. Mullen, D. W. Rose, M. G. Rosenfeld, and C. K. Glass. 1997. Nuclear integration of JAK/STAT and Ras/AP-1 signaling by CBP and p300. Proc. Natl. Acad. Sci. USA. 94: 1074-1079.
66. Hansson, G. K., L. Jonasson, J. Holm, M. M. Clowes, and A. W. Clowes. 1988. Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Cin. Res. 63: 712-719.
67. Geng, Y. J., Q. Wu, M. Muszynski, G. K. Hansson, and P. Libby. 1996. Apoptosis of vascular smooth muscle cells induced by in vitro stimulation with interferon-gamma, tumor necrosis factor-alpha, and interleukin-1 beta. Arterioscler. Thromb. Vasc. Biol. 16: 19-27.
68. de Whalley, C. V., and D. W. H. Riches. 1991. Influence of the cytocidal macrophage phenotype on the degradation of acetylated low density lipoproteins-dual regulation of scavenger receptor activity and of intracellular degradation of endocytosed ligand. Exp. Cell Res. 192: 460-468.
69. Grewal, T., E. Priceputu, J. Davignon, and L. Bernier. 2001. Identification of a gamma-interferon-responsive element in the promoter of the human macrophage scavenger receptor A gene. Arterioscler. Thromb. Vasc. Biol. 21: 825-831.
70. Van der Kooij, M. A., O. H. Morand, H. J. Kempen, and T. J. C. van Berkel. 1996. Decrease in scavenger receptor expression in human monocyte-derived macrophages treated with granulocyte macrophage colony-stimulating factor. Arterioscler. Thromb. Vasc. Biol. 16:106-114.
71. van Lenten, B. J., and A. M. Fogelman. 1992. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-alpha. J. Immunol. 148: 112-116.
72. Roselaar, S. E., and A. Daugherty. 1997. Lipopolysaccharide decreases scavenger receptor mRNA in vivo.y. Interferon Cytokine Res. 17: 573-579.
73. Fitzgerald, M. L., K. J. Moore, M. W. Freeman, and G. L. Reed. 2000. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: a divergent response relative to human THP-1 monocyte/macrophages. J. Immunol. 164: 2692-2700.
74. Hsu, H. Y., A. C. Nicholson, and D. P. Hajjar. 1996. Inhibition of macrophage scavenger receptor activity by tumor necrosis factor-alpha is transcriptionally and post-transcriptionally regulated. J. Biol. Chem. 271: 7767-7773.
75. Schreyer, S. A., J. J. Peschon, and R. C. LeBoeuf. 1996. Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55. J. Biol. Chem. 271: 26174-26178.
76. Hsu, H. Y., and Y. C. Twu. 2000. Tumor necrosis factor-alpha-mediated protein kinases in regulation of scavenger receptor and foam cell formation on macrophage. J. Biol. Chem. 275: 41035-41048.
77. Endemann, G., L. W. Stanton, K. S. Madden, C. M. Bryant, R. T. White, and A. A. Protter. 1993. CD36 is a receptor for oxidized low density lipoprotein. J. Biol. Chem. 268: 11811-11816.
78. Febbraio, M., E. A. Podrez, J. D. Smith, D. P. Hajjar, S. L. Hazen, H. F. Hoff, K. Sharma, and R. L. Silverstein. 2000. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J. Clin. Invest. 105: 1049-1056.
79. Febbraio, M., E. Guy, and R. L. Silverstein. 2004. Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 24: 2333-2338.
80. Feng, J. W., J. H. Han, S. F. A. Pearce, R. L. Silverstein, A. M. Gotto, D. P. Hajjar, and A. C. Nicholson. 2000. Induction of CD36 expression by oxidized LDL and IL-4 by a common signaling pathway dependent on protein kinase C and PPAR-gamma. J. Lipid Res. 41:688-696.
81. Yesner, L. M., H. Y. Huh, S. F. Pearce, and R. L. Silverstein. 1996. Regulation of monocyte CD36 and thrombospondin-1 expression by soluble mediators. Arterioscler. Thromb. Vasc. Biol. 16: 1019-1025.
82. Panousis, C. G., and S. H. Zuckerman. 2000. Regulation of cholesterol distribution in macrophage-derived foam cells by interferon-gamma. J. Lipid Res. 41: 75-83.
83. Nakagawa, T., S. Nozaki, M. Nishida, J. M. Yakub, Y. Tomiyama, A. Nakata, K. Matsumoto, T. Funahashi, K. Kameda-Takemura, Y. Kurata, et al. 1998. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages. Arterioscler. Thromb. Vasc. Biol. 18: 1350-1357.
84. Han, J. H., D. P. Hajjar, J. M. Tauras, J. W. Feng, A. M. Gotto, and A. C. Nicholson. 2000. Transforming growth factor-beta 1 (TGF-beta 1) and TGF-beta 2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma. J. Biol. Chem. 275: 1241-1246.
85. Zuckerman, S. H., C. Panousis, and G. Evans. 2001. TGF-beta reduced binding of high-density lipoproteins in murine macrophages and macrophage-derived foam cells. Atherosclerosis. 155: 79-85.
86. Sawamura, T., N. Kume, T. Aoyama, H. Moriwaki, H. Hoshikawa, Y. Aiba, T. Tanaka, S. Miwa, Y. Katsura, T. Kita, et al. 1997. An endothelial receptor for oxidized low-density lipoprotein. Nature. 386: 73-77.
87. Yoshida, H., N. Kondratenko, S. Green, D. Steinberg, and O. Quehenberger. 1998. Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor. Biochem. J. 334: 9-13.
88. Moriwaki, H., N. Kume, H. Kataoka, T. Murase, E. Nishi, T. Sawamura, T. Masaki, and T. Kita. 1998. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: upregulated expression by TNF-alpha. FEBS Lett. 440: 29-32.
89. Kume, N., H. Moriwaki, H. Kataoka, M. Minami, T. Murase, T. Sawamura, T. Masaki, and T. Kita. 2000. Inducible expression of LOX-1, a novel receptor for oxidized LDL, in macrophages and vascular smooth muscle cells. Ann. N. Y. Acad. Sci. 902: 323-327.
90. Chiba, Y., T. Ogita, K. Ando, and T. Fujita. 2001. PPARgamma ligands inhibit TNF-alpha-induced LOX-1 expression in cultured endothelial cells. Biochem. Biophys. Res. Commun. 286: 541-546.
91. Acton, S. L., P. E. Scherer, H. F. Lodish, and M. Krieger. 1994. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J. Biol. Chem. 269: 21003-21009.
92. Acton, S., A. Rigotti, K. T. Landschulz, S. Z. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
93. van Eck, M., I. S. Bos, R. B. Hildebrand, B. T. van Rij, and T. J. van Berkel. 2004. Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am. J. Pathol. 165: 785-794.
94. Zhang, W. W., P. G. Yancey, Y. R. Su, V. R. Babaev, Y. M. Zhang, S. Fazio, and M. F. Linton. 2003. Inactivation of macrophage scavenger receptor class B type I promotes atherosclerotic lesion development in apolipoprotein E-deficient mice. Circulation. 108: 2258-2263.
95. Hirano, K., S. Yamashita, Y. Nakagawa, T. Ohya, F. Matsuura, K. Tsukamoto, Y. Okamoto, A. Matsuyama, K. Matsumoto, J. Miyagawa, et al. 1999. Expression of human scavenger receptor class B type I in cultured human monocyte-derived macrophages and atherosclerotic lesions. Circ. Res. 85: 108-116.
96. Buechler, C., M. Ritter, C. D. Quoc, A. Agildere, and G. Schmitz. 1999. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem. Biophys. Res. Commun. 262: 251-254.
97. Feng, B., D. J. Zhang, G. Kuriakose, C. M. Devlin, M. Kockx, and I. Tabas, 2003. Niemann-Pick C heterozygosity confers resistance to lesional necrosis and macrophage apoptosis in murine atherosclerosis. Proc. Natl. Acad. Sci. USA. 100: 10423-10428.
98. Tabas, I. 2002. Consequences of cellular cholesterol accumulation: basic concepts and physiological implications. J. Clin. Invest. 110: 905-911.
99. Reiss, A. B., C. A. Patel, M. M. Rahman, E. S. Chan, K. Hasneen, M. C. Montesinos, J. D. Trachman, and B. N. Cronstein. 2004. Interferon-gamma impedes reverse cholesterol transport and promotes foam cell transformation in THP-1 human monocytes/macrophages. Med. Sci. Monit. 10: BR420-BR425.
100. Yang, J. B., Z. J. Duan, W. Yao, O. Lee, L. Yang, X. Y. Yang, X. Sun, C. C. Chang, T. Y. Chang, and B. L. Li. 2001. Synergistic transcriptional activation of human acyl-coenzyme A:cholesterol acyltransterase-1 gene by interferon-gamma and all-trans-retinoic acid THP-1 cells. J. Biol. Chem. 276: 20989-20998.
101. Hori, M., A. Miyazaki, H. Tamagawa, M. Satoh, K. Furukawa, H. Hakamata, Y. Sasaki, and S. Horiuchi. 2004. Up-regulation of acyl-coenzyme A:cholesterol acyltransferase-1 by transforming growth factor-beta1 during differentiation of human monocytes into macrophages. Biochem. Biophys. Res. Commun. 320: 501-505.
102. Inaba, T., H. Shimano, T. Gotoda, K. Harada, M. Shimada, M. Kawamura, Y. Yazaki, and N. Yamada. 1993. Macrophage colony-stimulating factor regulates both activities of neutral and acidic cholesteryl ester hydrolases in human monocyte-derived macrophages. J. Clin. Invest. 92: 750-757.
103. Björkhem, I., O. Andersson, U. Diczfalusy, B. Sevastik, R. J. Xiu, C. G. Duan, and E. Lund. 1994. Atherosclerosis and sterol 27-hydroxylase: evidence for a role of this enzyme in elimination of cholesterol from human macrophages. Proc. Natl. Acad. Sci. USA. 91: 8592-8596.
104. Reiss, A. B., N. W. Awadallah, S. Malhotra, M. C. Montesinos, E. S. L. Chan, N. B.Javitt, and B. N. Cronstein. 2001. Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages. J. Lipid Res. 42: 1913-1922.
105. Reiss, A. B., M. M. Rahman, E. S. Chan, M. C. Montesinos, N. W. Awadallah, and B. N. Cronstein. 2004. Adenosine A2A receptor occupancy stimulates expression of proteins involved in reverse cholesterol transport and inhibits foam cell formation in macrophages. J. Leukoc. Biol. 76: 727-734.
106. Bellosta, S., R. W. Mahley, D. A. Sanan, J. Murata, D. L. Newland, J. M. Taylor, and R. E. Pitas. 1995. Macrophage-specific expression of human apolipoprotein E reduces atherosclerosis in hypercholesterolemic apolipoprotein E-null mice. J. Clin. Invest. 96: 2170-2179.
107. Lin, C. Y., H. Duan, and T. Mazzone. 1999. Apolipoprotein E-dependent cholesterol efflux from macrophages: kinetic study and divergent mechanisms for endogenous versus exogenous apolipoprotein E. J. Lipid Res. 40: 1618-1627.
108. Huang, Z. H., and T. Mazzone. 2002. ApoE-dependent sterol efflux from macrophages is modulated by scavenger receptor class B type I expression. J. Lipid Res. 43: 375-382.
109. Zuckerman, S. H., G. F. Evans, and L. O'Neal. 1992. Cytokine regulation of macrophage apo-E secretion-opposing effects of GM-CSF and TGF-beta. Atherosclerosis. 96: 203-214.
110. Tall, A. R. 2003. ATVB in focus-role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transport. Arterioscler. Thromb. Vasc. Biol. 23: 710-711.
111. Panousis, C. G., and S. H. Zuckerman. 2000. Interferon-gamma induces downregulation of Tangier disease gene (ATP-binding-cassette transporter 1) in macrophage-derived foam cells. Arterioscler. Thromb. Vasc. Biol. 20: 1565-1571.
112. Wang, X. Q., C. G. Panousis, M. L. Alfaro, G. F. Evans, and S. H. Zuckerman. 2002. Interferon-gamma-mediated downregulation of cholesterol efflux and ABC1 expression is by the Stat1 pathway. Arterioscler. Thromb. Vasc. Biol. 22: E5-E9.
113. Panousis, C. G., G. Evans, and S. H. Zuckerman. 2001. TGF-beta increases cholesterol efflux and ABC-1 expression in macrophage-derived foam cells: opposing the effects of IFN-gamma. J. Lipid Res. 42: 856-863.
114. Luttun, A., E. Lutgens, A. Manderveld, K. Maris, D. Collen, P. Carmeliet, and L. Moons. 2004. Loss of matrix metalloproteinase-9 or matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic media destruction but differentially affects plaque growth. Circulation. 109: 1408-1414.
115. Corcoran, M. L., W. G. Stetler-Stevenson, P. D. Brown, and L. M. Wahl. 1992. Interleukin 4 inhibition of prostaglandin E2 synthesis blocks interstitial collagenase and 92-kDa type IV collagenase/gelatinase production by human monocytes. J. Biol. Chem. 267: 515-519.
116. Yoo, H. G., B. A. Shin, J. S. Park, K. H. Lee, K. O. Chay, S. Y. Yang, B. W. Ahn, and Y. D. Jung. 2002. IL-1 beta induces MMP-9 via reactive oxygen species and NF-kappa B in murine macrophage RAW 264.7 cells. Biochem. Biophys. Res. Commun. 298: 251-256.
117. Lacraz, S., L. P. Nicod, R. Chicheportiche, H. G. Welgus, and J. M. Dayer. 1995. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J. Clin. Invest. 96: 2304-2310.
118. Kumada, M., S. Kihara, N. Ouchi, H. Kobayashi, Y. Okamoto, K. Ohashi, K. Maeda, H. Nagaretani, K. Kishida, N. Maeda, et al. 2004. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation. 109: 2046-2049.
119. Ogawa, K., F. Chen, C. Kuang, and Y. Chen. 2004. Suppression of matrix metalloproteinase-9 transcription by transforming growth factor-beta is mediated by a nuclear factor-kappaB site. Biochem. J. 381: 413-422
120. Zhang, Y., K. McCluskey, K. Fujii, and L. M. Wahl. 1998. Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1 beta through prostaglandin-dependent and -independent mechanisms. J. Immunol. 161: 3071-3076.
121. Castrillo, A., S. B. Joseph, C. Marathe, D. J. Mangelsdorf, and P. Tontonoz. 2003. Liver X receptor-dependent repression of matrix metalloproteinase-9 expression in macrophages. J. Biol. Chem. 278: 10443-10449.
122. Xiong, W., Y. Zhao, A. Prall, T. C. Greiner, and B. T. Baxter. 2004. Key roles of CD4(+) T cells and IFN-gamma in the development of abdominal aortic aneurysms in a murine model. J. Immunol. 172: 2607-2612.
123. Shapiro, S. D., E. J. Campbell, D. K. Kobayashi, and H. G. Welgus. 1990. Immune modulation of metalloproteinase production in human macrophages. Selective pretranslational suppression of interstitial collagenase and stromelysin biosynthesis by interferon-gamma. J. Clin. Invest. 86: 1204-1210.
124. Xie, B., Z. Dong, and I. J. Fidler. 1994. Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages. J. Immunol. 152: 3637-3644.
125. Daugherty, A., and D. L. Rateri. 2002. T lymphocytes in atherosclerosis-the yin-yang of Th1 and Th2 influence on lesion formation. Circ. Res. 90: 1039-1040.
126. Corti, R., R. Hutter, J. J. Badimon, and V. Fuster. 2004. Evolving concepts in the triad of atherosclerosis, inflammation and thrombosis. J. Thromb. Thrombolysis. 17: 35-44.
127. Wilcox, J. N., K. M. Smith, S. M. Schwartz, and D. Gordon. 1989. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc. Natl. Acad. Sci. USA. 86: 2839-2843.
128. Toschi, V., R. Gallo, M. Lettino, J. T. Fallon, S. D. Gertz, A. Fernandez Ortiz, J. H. Chesebro, L. Badimon, Y. Nemerson, V. Fuster, et al. 1997. Tissue factor modulates the thrombogenicity of human atherosclerotic plaques. Circulation. 95: 594-599.
129. Del Prete, G., M. De Carli, R. M. Lammel, M. M. D'Elios, K. C. Daniel, B. Giusti, R. Abbate, and S. Romagnani. 1995. Th1 and Th2 T-helper cells exert opposite regulatory effects on procoagulant activity and tissue factor production by human monocytes. Blood. 86: 250-257.
130. Osnes, L. T., A. B. Westvik, G. B. Joo, C. Okkenhaug, and P. Kierulf. 1996. Inhibition of IL-1 induced tissue factor (TF) synthesis and procoagulant activity (PCA) in purified human monocytes by IL-4, IL-10 and IL-13. Cytokine. 8: 822-827.
131. Scheibenbogen, C., H. Moser, S. Krause, and R. Andreesen. 1992. Interferon-gamma-induced expression of tissue factor activity during human monocyte to macrophage maturation. Haemostasis. 22: 173-178.
132. Schwager, I., and T. W. Jungi. 1994. Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood. 83: 152-160.
133. -/- mice. J. Interferon Cytokine Res. 22: 661-670.
134. Gupta, S., A. M. Pablo, X. C. Jiang, N. Wang, A. R. Tall, and C. Schindler. 1997. IFN-gamma potentiates atherosclerosis in apoE knock-out mice. J. Clin. Invest 99: 2752-2761.
135. Buono, C., C. E. Come, G. Stavrakis, G. F. Maguire, P. W. Connelly, and A. H. Lichtman. 2003. Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse. Arterioscler. Thromb. Vasc. Biol. 23: 454-460.
136. Lee, T. S., H. C. Yen, C. C. Pan, and L. Y. Chau. 1999. The role of interleukin 12 in the development of atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 19: 734-742.
137. -/- mice. Am. J. Pathol. 157: 1819-1824.
138. -/- mice through release of interferon-gamma. Circ. Res. 90: E34-E38.
139. Niwa, T, H. Wada, H. Ohashi, N. Iwamoto, H. Ohta, H. Kirii, H. Fujii, K. Saito, and M. Seishima. 2004. Interferon-gamma produced by bone marrow-derived cells attenuates atherosclerotic lesion formation in LDLR-deficient mice. J. Atheroscler. Thromb. 11: 79-87.
140. Linton, M. F., J. B. Atkinson, and S. Fazio. 1995. Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation. Science. 267: 1034-1037.
141. Boisvert, W. A., J. Spangenberg, and L. K. Curtiss. 1995. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation. J. Clin. Invest. 96: 1118-1124.
142. Boisvert, W. A., R. Santiago, L. K. Curtiss, and R. A. Terkeltaub. 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101: 353-363.
143. Ishibashi, M., K. Egashira, Q. Zhao, K. I. Hiasa, K. Ohtani, Y Ihara, I. F. Charo, S. Kura, T. Tsuzuki, A. Takeshita, et al. 2004. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler. Thromb. Vasc. Biol. 24: e174-e178.
144. Sata, M., A. Saiura, A. Kunisato, A. Tojo, S. Okada, T. Tokuhisa, H. Hirai, M. Makuuchi, Y. Hirata, and R. Nagai. 2002. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat. Med. 8: 403-409.
145. Rauscher, F. M., P. J. Goldschmidt Clermont, B. H. Davis, W. Tang, D. Gregg, R. Ramaswami, A. M. Pippen, B. H. Annex, C. M. Dong, and D. A. Taylor.
146. Zhang, D., W. Tang, P. M. Yao, C. W. Yang, B. X. Xie, S. Jackowski, and I. Tabas. 2000. Macrophages deficient in CTP:phosphocholine cytidylyltransferase-alpha are viable under normal culture conditions but are highly susceptible to free cholesterol-induced death-molecular genetic evidence that the induction of phosphatidylcholine biosynthesis in free cholesterol-loaded macrophages is an adaptive response. J. Biol. Chem. 275: 35368-35376.
147. Kanters, E., M. Pasparakis, M. J. J. Gijbels, M. N. Vergouwe, I. Partouns Hendriks, R. J. A. Fijneman, B. E. Clausen, I. Forster, M. M. Kockx, K. Rajewsky, et al. 2003. Inhibition of NF-kappa B activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112: 1176-1185.
148. Draude, G., and R. L. Lorenz. 2000. TGF-beta 1 downregulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages. Am. J. Physiol. Heart Circ. Physiol. 278: H1042-H1048.
149. Nishimura, N., M. Harada Shiba, S. Tajima, R. Sugano, T. Yamamura, Q. Z. Qiang, and A. Yamamoto. 1998. Acquisition of secretion of transforming growth factor-beta 1 leads to autonomous suppression of scavenger receptor activity in a monocyte-macrophage cell line, THP-1. J. Biol. Chem. 273: 1562-1567.
150. Bottalico, L. A., R. E. Wager, L. B. Agellon, R. K. Assoian, and I. Tabas. 1991. Transforming growth factor-beta1 inhibits scavenger receptor activity in THP-1 human macrophages. J. Biol. Chem. 266: 22866-22871.
151. Liao, H. S., A. Matsumoto, H. Itakura, T. Doi, M. Honda, T. Kodama, and Y. J. Geng. 1999. Transcriptional inhibition by interleukin-6 of the class A macrophage scavenger receptor in macrophages derived from human peripheral monocytes and the THP-1 monocytic cell line. Arterioscler. Thromb. Vasc. Biol. 19: 1872-1880.
152. de Villiers, W. J. S., I. P. Fraser, D. A. Hughes, A. G. Doyle, and S. Gordon. 1994. Macrophage-colony-stimulating factor selectively enhances macrophage scavenger receptor expression and function. J. Exp. Med. 180: 705-709.
153. de Villiers, W. J. S., I. P. Fraser, and S. Gordon. 1994. Cytokine and growth factor regulation of macrophage scavenger receptor expression and function. Immunol. Lett. 43: 73-79.
154. Minami, M., N. Kume, H. Kataoka, M. Morimoto, K. Hayashida, T. Sawamura, T. Masaki, and T. Kita. 2000. Transforming growth factor-beta(1) increases the expression of lectin-like oxidized low-density lipoprotein receptor-1. Biochem. Biophys. Res. Commun. 272: 357-361.
155. Higuchi, S., A. Tanimoto, N. Arima, H. Xu, Y. Murata, T. Hamada, K. Makishima, and Y. Sasaguri. 2001. Effects of histamine and interleukin-4 synthesized in arterial intima on phagocytosis by monocytes/macrophages in relation to atherosclerosis. FEBS Lett. 505: 217-222.
156. Wuttge, D. M., X. Zhou, Y. Sheikine, D. Wagsater, V. Stemme, U. Hedin, S. Stemme, G. K. Hansson, and A. Sirsjo. 2004. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 24: 750-755.
157. Brand, K., N. Mackman, and L. K. Curtiss. 1993. Interferon-gamma inhibits macrophage apolipoprotein-E production by posttranslational mechanisms. J. Clin. Invest. 91: 2031-2039.
158. Duan, H. W., Z. G. Li, and T. Mazzone. 1995. Tumor necrosis factor-alpha modulates monocyte/macrophage apoprotein E gene expression. J. Clin. Invest. 96: 915-922.